Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogesh Goyal

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kime, Deepanwita Bose, Mariluz Arainga, et al.
Research Square|May 3, 2023
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous MelanomaVito Rebecca, Kasturee Jagirdar, Marie Portuallo, et al.
Oncogene|December 8, 2023
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanomaKasturee Jagirdar, Marie E Portuallo, Meihan Wei, et al.
Iscience|February 18, 2026
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatmentVito W Rebecca, Min Xiao, Andrew Kossenkov, et al.
Cell Systems|December 18, 2025
Integrating synthetic biology to understand and engineer the heart, lung, blood, and sleep systemsElliot L Chaikof, Jichao Chen, Martha U Gillette, et al.
Nature|July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cellsYogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kime, Deepanwita Bose, Mariluz Arainga, et al.
Research Square|May 3, 2023
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous MelanomaVito Rebecca, Kasturee Jagirdar, Marie Portuallo, et al.
Oncogene|December 8, 2023
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanomaKasturee Jagirdar, Marie E Portuallo, Meihan Wei, et al.
Iscience|February 18, 2026
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatmentVito W Rebecca, Min Xiao, Andrew Kossenkov, et al.
Cell Systems|December 18, 2025
Integrating synthetic biology to understand and engineer the heart, lung, blood, and sleep systemsElliot L Chaikof, Jichao Chen, Martha U Gillette, et al.
Nature|July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cellsYogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.
Pageof 6